A Stock You Should Be Looking At: Rubius Therapeutics Inc. (NASDAQ:RUBY)

The price of Rubius Therapeutics Inc. (NASDAQ: RUBY) closed at $0.26 in the last session, up 3.44% from day before closing price of $0.25. In other words, the price has increased by $+0.0086 from its previous closing price. On the day, 1111995 shares were traded. RUBY stock price reached its highest trading level at $0.2695 during the session, while it also had its lowest trading level at $0.2401.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

Ratios:

We take a closer look at RUBY’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.40 and its Current Ratio is at 3.40. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 2.10.

Upgrades & Downgrades

SVB Leerink Downgraded its Outperform to Mkt Perform on March 13, 2020, whereas the target price for the stock was revised from $19 to $4.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 10 when Appelhans Dannielle sold 5,737 shares for $0.80 per share. The transaction valued at 4,590 led to the insider holds 6,763 shares of the business.

Epstein David R bought 30,000 shares of RUBY for $43,329 on Apr 21. The Director now owns 4,720,012 shares after completing the transaction at $1.44 per share. On Feb 01, another insider, CAGNONI PABLO J, who serves as the CEO and President of the company, sold 6,730 shares for $6.57 each. As a result, the insider received 44,236 and left with 35,520 shares of the company.

Stock Price History:

Over the past 52 weeks, RUBY has reached a high of $7.76, while it has fallen to a 52-week low of $0.14. The 50-Day Moving Average of the stock is 0.2081, while the 200-Day Moving Average is calculated to be 0.7756.

Shares Statistics:

According to the various share statistics, RUBY traded on average about 1.23M shares per day over the past 3-months and 2.08M shares per day over the past 10 days. A total of 90.36M shares are outstanding, with a floating share count of 84.40M. Insiders hold about 5.51% of the company’s shares, while institutions hold 76.60% stake in the company. Shares short for RUBY as of Oct 13, 2022 were 2.67M with a Short Ratio of 2.04M, compared to 2.51M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 2.95% and a Short% of Float of 7.99%.

Earnings Estimates

The company has 3 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.39 for the current quarter, with a high estimate of -$0.3 and a low estimate of -$0.44, while EPS last year was -$0.55. The consensus estimate for the next quarter is -$0.27, with high estimates of -$0.19 and low estimates of -$0.34.

Analysts are recommending an EPS of between -$1.56 and -$1.85 for the fiscal current year, implying an average EPS of -$1.74. EPS for the following year is -$0.7, with 3 analysts recommending between -$0.32 and -$0.98.